Prevalence and clinical significance of antibiotic resistance in Helicobacter pylori;Prevalencia y significado clínico de resistencia antibiótica de Helicobacter pylori

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 10, 2000, Pages 651-660

  Garcia Diaz E ^a   Romero Gomez M ^a   Vargas, J ^a   Guil, A ^a   Bernal, S ^a   Castro, M ^a  

^a NONE   (Spain)

Author keywords

Antibiotic resistance; Eradication; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; SPAIN;

EID: 8844224900     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Helicobacter pylori
2. Peptic ulcer disease
3. Helicobacter pylori in peptic ulcer disease
4. pH and HP-gastric acid secretion and H. pylori: Implications for ulcer healing and erradication of the organism
5. Effect of treatment of H. pylori infection on the long-term recurrence of gastric o duodenal ulcer: A randomized, controlled study
6. Antibacterial treatment of gastric ulcers associated with H. pylori
7. Problemas de resistencia a antibióticos en la erradicación del H. pylori
8. Resistance of Helicobacter pylori to antibiotics
9. Resistencias bacterianas en la infección por H. pylori: Un problema actual que amenaza el futuro
10. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer
11. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa
12. Choosing the best anti-H. pylori therapy: Effect of antimicrobial resistence
13. Emerging patterns of Helicobacter pylori (H. pylori) antimicrobial resistance in Europe
14. High prevalence of H. pylori metronidazole resistance in migrants to east London: Relation with previous nitromidazole exposure and grastroduodenal disease
15. Y European multicenter study group on antibiotic susceptibility of H. pylori. Results of a multi-center European survey in 1991 of metronidazole resistance in H. pylori
16. Evolution of resistance to metronidazole and clarithromycin in H. pylori clinical isolates from Spain
17. Microbiologic diagnosis of Helicobacter pylori and its resistance to antibiotics
18. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany
19. Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori
20. Characterist and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years
21. Role of metronidazole resistance in therapy of Helicobacter pylori infections
22. Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by tryple therapy
23. Peptic ulcer disease in the 1990s: A Asian perspective
24. Helicobacter pylori in Africa: Observations on an «enigma within an enigma»
25. Metronidazole resistance in H. pylori
26. Age dependent eradication of Helicobacter pylori with dual therapy
27. Short report: Smoking habits and acquisition of metronidazole resistance in patients with H. pylori-related gastritis
28. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori
29. Proton pump inhibitor pretreatment affects Helicobacter pylori sensitivity to antibiotics
30. Coccoid like forms (CLF) of Helicobacter pylori. Enzyme activity and antigenicity
31. Metronidazole-resistant H. pylori: Of questionable clinical importance
32. The effect of antibiotic resistance on the outcome of three 1 week triple therapies against Helicobacter pylori
33. Pretreatment antibiotic resistance in Helicobacter pylori infection: Results of three randomized controlled studies
34. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycilin in patients with metronidazole-resistant or susceptible Helicobacter pylori strains
35. A new quadruple therapy for Helicobacter pylori: Influence of resistance strains on treatment outcome
36. Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice
37. Antibiotic resistance in Helicobacter pylori: Implication for therapy
38. Use of E-test to determine the in vitro activity of metronidazole in Helicobacter pylori clinical isolates
39. Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori
40. Development of resistant Helicobacter pylori in Sweden: Tendency toward increasing resistance to clarithromycine
41. Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing
42. Metronidazole sensivity testing of Helicobacter pylori: The importance of media
43. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: A prospective study of 1-week lansoprazole, amoxicilin and clarithromycin in active peptic ulcer
44. Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori
45. Antibiotic resistance mechanism of Helicobacter pylori
46. Nitazoxanide, a potencial drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole
47. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti Helicobacter pylori regimens: A meta-analysis
48. Co-detection of Helicobacter pylori and of its resistance to clarithromyci by PCR